UPDATE 3-Mylan shares slide after warning of hit to revenue
November 05, 2019 at 13:03 PM EST
Generic drugmaker Mylan NV said on Tuesday reevaluation of its portfolio of medicines will continue next year and cautioned of a hit to revenue, and its shares nearly 6%.
